AVDL

Avadel Pharmaceuticals plc Ordinary Share

21.57

USD

AVDL Earnings Reports

Positive Surprise Ratio

AVDL beat 22 of 40 last estimates.

55%

Next Report

Date of Next Report

Mar 02, 2026

Estimate for Q4 25 (Revenue/ EPS)

$80.25M

$0.09

Implied change from Q3 25 (Revenue/ EPS)

+3.59%

Implied change from Q4 24 (Revenue/ EPS)

+59.20%

-280.00%

Avadel Pharmaceuticals plc Ordinary Share earnings per share and revenue

On Nov 04, 2025, AVDL reported earnings of 0.00 USD per share (EPS) for Q3 25, missing the estimate of 0.06 USD, resulting in a -100.00% surprise. Revenue reached 77.47 million, compared to an expected 75.05 million, with a 3.23% difference. The market reacted with a +0.32% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 12 analysts forecast an EPS of 0.09 USD, with revenue projected to reach 80.25 million USD, implying an -- of --% EPS, and increase of 3.59% in Revenue from the last quarter.

FAQ

What were Avadel Pharmaceuticals plc Ordinary Share's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Avadel Pharmaceuticals plc Ordinary Share reported EPS of $0.00, missing estimates by -100%, and revenue of $77.47M, 3.23% above expectations.

How did the market react to Avadel Pharmaceuticals plc Ordinary Share's Q3 2025 earnings?

The stock price moved up 0.32%, changed from $18.90 before the earnings release to $18.96 the day after.

When is Avadel Pharmaceuticals plc Ordinary Share expected to report next?

The next earning report is scheduled for Mar 02, 2026.

What are the forecasts for Avadel Pharmaceuticals plc Ordinary Share's next earnings report?

Based on 12 analysts, Avadel Pharmaceuticals plc Ordinary Share is expected to report EPS of $0.09 and revenue of $80.25M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.